S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid

Cancer Research

Volumn 60, Issue 7, 2000, Pages 2025-2032

  Zhang, Yuxiang ^a,b   Rishi, Arun K ^a,b   Dawson, Marcia I ^c   Tschang, Rainbow ^a,b   Farhana, Lulu ^a,b   Boyanapalli, Madanamohan ^a,b   Reichert, Uwe ^d   Shroot, Braham ^d   Van Buren, Eric C ^b   Fontana, Joseph A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c Palo Alto Institute of Molecular Medicine   (United States)

^d Ctr Intl Rescherches D   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; CYCLIN DEPENDENT KINASE 2; PROTEIN P21; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA-GALACTOSIDASE; BREAST; CELL CYCLE; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASES; EPITHELIAL CELLS; FEMALE; GENES, REPORTER; HUMANS; LUCIFERASES; RECEPTORS, RETINOIC ACID; RETINOIDS; S PHASE; TRANSFECTION;

EID: 0034070373     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Gudas, L. J., Sporn, M. B., and Roberts, A. B. Cellular biology and biochemistry of the retinoids. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, 2nd ed., pp. 443-520. New York: Raven Press, 1994.
2. Hofmann, C., and Eichele, G. Retinoids in development. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, 2nd ed., pp. 387-442. New York: Raven Press, 1994.
3. Bollag, W., Apfel, C., and LeMotte, P. Retinoids: achievements, prospectives, and future goals. In: S. Waxman (ed.), Differentialion Therapy: Challenges of Modern Medicine, Vol. 10., pp. 285-302. Rome: Ares-Serono Symposia Publications, 1995.
4. Bollag, W. Isnardi, L., Jablonska, S., Klaus, M., Majewski, S., Pirson, W., and Toma, S. Links between pharmacological properties of retinoids and nuclear retinoid receptors. Int. J. Cancer, 70: 470-472, 1997.
5. Xu, X. C., Lee, J. S., Lee, J. J., Morice, R. C., Liu, X., Lippman, S. M., Hong, W. K., and Lotan, R. Nuclear retinoic acid receptors β in bronchial epithelium of smokers before and during chemoprevention. J. Natl. Cancer Inst., 91: 1317-1321, 1999.
6. Hong, W. K., and Itri, L. M. Retinoids and human cancer. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, 2nd ed., pp. 597-630. New York: Raven Press, 1994.
7. Chambon, P. The retinoid signaling pathway: molecular and genetic analyses. Semin. Cell Biol., 5: 115-125, 1994.
8. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. The retinoid receptors. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoid Receptors: Biology, Chemistry, and Medicine, 2nd ed., pp. 319-349. New York: Raven Press, 1994.
9. Kirfel, I., Kelter, M. Cancela, L. M., Price, P. A., and Schele, R. Identification of a novel negative retinoic acid responsive element in the promoter of the human Matrix Gla protein gene. Proc. Natl. Acad. Sci. USA, 94: 2227-2232, 1997.
10. Pfahl, M. Nuclear receptor/AP-1 interaction. Endocr. Rev., 14: 651-658, 1993.
11. Agadir, A., Shealy, Y. F., Hill, D. L., and Zhang, X-K. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells. Cancer Res., 57: 3444-3450, 1997.
12. Lee, H-Y., Dawson, M. I., Claret, F-X., Chen, J. D., Walsh, G. L., Hong, W. K., and Kurie, J. M. Evidence of a retinoid signaling alteration involving the activator protein 1 complex in tumorigenic human bronchial epithelial cells and non-small cell lung cancer cells. Cell Growth Differ., 8: 283-291, 1997.
13. Fitzgerald, P., Teng, M., Chandraratna, R. A. S., Heyman, R. A., and Allegretto, E. A. Retinoic acid receptor α expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res., 57: 2642-2650, 1997.
14. Dawson, M. I., Chao, W. R., Pine, P., Jong, L., Hobbs, P. D., Rudd, C., Quick, T. C., Niles, R. M., Zhang, X., Lombardo, A., Ely, K. R., Shroot, B., and Fontana, J. A. Correlation of retinoid binding affinity to RARα with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res., 55: 4446-4451, 1995.
15. Roman, S. D., Ormandy, C. J., Manning, D. L., Blamey, R. W., Nicholson, R. I., Sutherland, R. L., and Clarke, C. L. Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res., 53: 5940-5945, 1993.
16. Rishi, A. K., Shao, Z-M., Baumann, R. G., Li, X-S., Sheikh, S., Kimura, S., Bashirelahi, N., and Fontana, J. A. Estradiol regulation of the human retinoic acid receptor α gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp 1 motifs. Cancer Res., 55: 4999-5006, 1995.
17. Sheikh, M. S., Shao, Z-M., Chen, J-C., Hussain, A., Jetten, A. M., and Fontana, J. A. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid. J. Cell. Biochem., 53: 394-404, 1993.
18. Van der Burg, B., van der Leede, B-M., Kwakenbos-Isbrucker, L., Salverda, S., De Laat, S. W., and van der Saag, P. T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Biol., 91: 149-157, 1993.
19. Rosenaver, A., Nervi, C., Davidson, K., Lamph, W. W., Mader, S., and Miller, W. H., Jr. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor α expression. Cancer Res., 58: 5110-5116, 1998.
20. 1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Differ., 8: 631-641, 1997.
21. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 11: 493-504, 1995.
22. Adachi, H., Adams, A., Hughes, F. M., Zhang, J., Cidlowski, J. A., and Jetten, A. M. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways. Cell Death Differ., 5: 973-983, 1998.
23. Hsu, C. A., Rishi, A. K., Li, X-S., Gerald, T. M., Dawson, M. I., Scheffer, C., Reichert. B., Shroot, B., Poirer, G. C., and Fontana, J. A. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood, 89: 4470-4479, 1997.
24. Charpentier, B., Bernardon, J. M., Evstache, J., Millois, C., Martin, B., Michel, S., and Shroot, B. Synthesis structure affinity relationships and biological activities of ligand binding to retinoic acid receptor subtypes. J. Med. Chem., 38: 4993-5006, 1995.
25. Sheikh, M. S., Li, X. S., Chen, J. C., Shao, Z. M., Ordonez, J. V., and Fontana, J. A. Mechanisms of regulation of WAF1/CIP1 gene expression in human breast carcinoma. Role of p53-dependent and independent signal transduction pathway. Oncogene, 9: 3407-3415, 1994.
26. Whitacre, C. M., Hashimoto, H., Tsai, M-L., Chatterjee, S., Berger, S. J., and Berger, J. A. Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res., 55: 3697-3701, 1995.
27. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem., 162: 156-161, 1987.
28. Li, X-S., Chen, J. C., Sheikh, M. S., Shao, Z. M., and Fontana, J. A. Retinoic acid inhibition of insulin like growth factor I stimulation of c-fos mRNA levels in a breast carcinoma cell line. Exp. Cell Res., 211: 68-73, 1994.
29. WAF1/CIP1 gene mediated by cis elements present in the 3′-untranslated region. Cancer Res., 57: 5129-5136, 1997.
30. Avis, I., Mathias, A., Unsworth, E. J., Miller, M. J., Cuttitta, F., Mulshine, J. L., and Jakowlew, S. B. Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid. Importance of bioavailability. Cell Growth Differ., 6: 485-492, 1995.
31. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
32. Steller, H., Mechanisms and genes of cellular suicide. Science (Washington DC), 267: 1445-1448, 1995.
33. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirer, G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early maker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
34. Krek, W., Ewen, M. E., Shirodkar, S., Arany, Z., Kaelin, W. G., Jr., and Livingston, D. M. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell, 78: 161-172, 1994.
35. Krek, W., Xu, G., and Livingston, D. M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell, 83: 1149-1158, 1995.
36. Qin, X-Q., Livingston, D. M., Kaelin, W. G., Jr., and Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
37. Dynlacht, B. D., Flores, D., Lees, J. A., and Harlow, E. Differential regulation of E2F transactivation by cyclin/cdk 2 complexes. Genes Dev., 8: 1772-1786, 1994.
38. Langdon, S. P., Rabiasz, G. J., Ritchie, A. A., Reichert, U., Buchan, P., Miller, W. R., and Smyth, J. F. Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo. Cancer Chemother. Pharmacol., 42: 429-432, 1998.
39. Schadendorf, D., Kern, M. A., Artuc, M., Pahl, H. L., Rosenbach, T., Fichtner, I., Nurnberg, W., Stuting, S., Stebut, E. V., Worm, M., Makki, A., Jurgovsky, K., Kolde, G., and Henz, B. M. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via induction of AP-1 in vitro and causes growth inhibition in xenografts in vivo. J. Cell Biol., 135: 1889-1898, 1996.
40. Lu, X-P., Fanjul, A., Picard, N., Pfahl, M., Rungta, D., Nareed-Hood, K., Carter, B., Piedrafita, J., Tang, S., Fabbrizio, E., and Pfahl, M. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat. Med., 3: 686-690, 1997.
41. Szondy, Z., Reichert, U., Bernardon, J. M., Michel, S., Toth, R., Ancian, P., Aszner, E., and Fesus, L. Induction of apoptosis by retinoids and retinoic acid receptor γ-selective compounds in mouse thymocytes through a novel apoptosis pathway. Mol. Pharmacol., 51: 972-982, 1997.
42. Liang, J-Y., Fontana, J. A., Rao, J. N., Ordonez, I. V., Dawson, M. I., Shroot, B., Wilber, J. F., and Feng, P. A synthetic retinoid, CD437, induces S-phase arrest and apoptosis in the human prostate cancer cells. LNCaP and PC-3. Prostate, 38: 228-236, 1999.
43. 1-S phase arrest of normal human mammary epithelial cells is independent of the level of 53 protein expression. Cell Growth Differ., 10: 49-59, 1999.
44. Hauser, P. J., Agrawal, D., and Pledger, W. J. Primary keratinocytes have an adhesion dependent S phase check point that is absent in immortalized cell lines. Oncogene, 17: 3083-3092, 1998.
45. Schwartz, J. K., Devoto, S. H., Smith, E. J., Chellapan, S. P., Jakoi, L., and Nevins, J. R. Interactions of the p107 and R6 proteins with E2F during the cell proliferation response. EMBO J., 12: 1013-1020, 1993.
46. 1-S regulatory genes. Mol. Cell. Biol., 15: 4215-4224, 1995.
47. Qin, X-Q., Livingston, D. M., Kaelin, W. G., Jr., and Adams, I. D. Deregulated transcription factor E2F-1 expression leads to S phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
48. Shan, B., and Lee, W. H. Deregulated expression of E2F-1 induces S phase arrest and leads to apoptosis. Mol. Cell. Biol., 14: 8166-8173, 1994.
49. Hang, Y. M., Ishiko, T., Nakada, S., Utsugisawa, T., Kato, T., and Yuan, Z-M. Role for E2F-1 in DNA damage-induced entry of cells into S phase. Cancer Res., 57: 3640-3643, 1997.
50. Blattner, C., Sparks, A., and Lane, D. Transcription factor E2F-1 is upregulated in response to DNA damage in a matter analogous to that of p53. Mol. Cell. Biol., 19: 3704-3713, 1999.
51. Xu, M., Sheppard, K-A., Peng, C-Y., Yee, A. S., and Piwnica-Worms, H. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA binding activity of E2F-1/ DP-1 by phosphorylation. Mol. Cell. Biol., 14: 8420-8431, 1994.
52. waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells. Cancer Res., 57: 2193-2199, 1997.
53. Cai, K., and Dynlacht, B. D. Activity and nature of p21 (WAF1) complexes during the cell cycle. Proc. Natl. Acad. Sci. USA, 95: 12254-12259, 1998.
54. WAF1/CIP1 expression in human cancer cells. Cancer Res., 56: 5055-5062, 1996.
55. Cryns, V., and Yuan, J. Proteases to die for. Genes Dev., 12: 1551-1570, 1998.
56. Adams, J. M., and Cory, S. The bcl-2 protein family: orbiters of cell survival. Science (Washington DC), 281: 1322-1326, 1998.